13421 Manchester Road, Ste. 201 | St. Louis, MO 63131 | 314.835.0600 | market-scope.com

Quarterly Trend Analysis of Cataract, Refractive, Glaucoma, and Retinal

United States Quarterly Update Reports

®

SURVEY RESPONSES RECEIVED IN 2019

2350

3500TOTAL SURGEONS

REPRESENTEDON 2019

YEARS OF SURVEY

EXPERIENCE

20+

12MONTH

SUBSCRIPTIONS

Market Scope has been surveying United States ophthalmologists quarterly for over 20 years. The resulting data are analyzed and presented in our Quarterly Update Reports.

These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends. Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

PUBLISHED Quarterly

About

Cataract Quarterly Updates

New in 2019 -- increased focus on SMILE (C2M) and corneal cross-linking, practice marketing & pricing strategies, and changes in surgical locations.

Refractive Quarterly Updates

New in 2019 -- tracked adoption of new premium IOL designs, new intraoperative technologies and pharmaceuticals, RLE and FLACS, and dry eye treatment trends.

• FLACS adoption & procedure volume;

• US market shares for IOLs, presbyopia correcting-IOLs, and toric IOLs;

• US IOL market shares by surgery locations;

• US market shares for phaco machines;

• US market shares for viscoelastic;

• Surgeon plans & expectations for cataract pharmaceutical use;

• Dry eye treatment trends;

• Use of MIGS in cataract surgery.

KEY METRICS

• Procedures by type: LASIK, surface ablation, SMILE, corneal inlays, phakic IOLs.

• Laser center ownership by market segment;

• Procedures by segment;

• Average refractive surgery fees by type;

• Location of surgery;

• Corporate laser centers by company;

• US market share of excimer lasers;

• Femto lasers used by responding surgeons;

• Corneal cross-linking.

KEY METRICS

ENTERPRISE LICENSE: $11,850 SINGLE-USER LICENSE: $7,900

ENTERPRISE LICENSE: $11,850 SINGLE-USER LICENSE: $7,900

Premium IOL Survey Share Femtosecond Laser Market Share

Refractive Fees by Procedure Type

Every quarter, Market Scope surveys 3,500+ doctors from all specialties in order to produce these updates. We survey on procedure volumes, pricing and fees, product preferences, treatment plans, adoption of new technologies, and much more.

Beyond survey data, Market Scope sources additional information from our proprietary disease models, database of refractive and cataract specialists, primary research, and public data sources. In some cases, this additional information is used to extrapolate survey data to total market estimates.

Glaucoma Quarterly Updates

New in 2019 -- focus on next-gen vitrectomy machine features and newly approved IVTs, and adoption plans for genetic screening.

Retinal Quarterly Updates

New in 2019 -- comprehensive analysis of MIGS stent devices, canal-based procedures, and newly approved glaucoma medications.

ENTERPRISE LICENSE: $13,125 SINGLE-USER LICENSE: $8,750

ENTERPRISE LICENSE: $16,850 SINGLE-USER LICENSE: $11,150

• IVT injections by disease and product;

• Use of Eylea, Lucentis, Avastin, Ozurdex, and Iluvien;

• DME treatments;

• Corticosteroid use;

• Photocoagulation volume and photocoagulators used;

• Vitrectomy volume and location;

• Reusable and disposable instruments;

• Visualization agents.

KEY METRICS

• Glaucoma treatment regimen;

• MIGS usage;

• Patient medication usage;

• Medication compliance;

• Glaucoma tube shunts;

• Glaucoma drainage devices;

• Other glaucoma devices and treatments;

• Laser trabeculoplasty;

• Interest level in investigational glaucoma treatments.

KEY METRICS

Our Process

Vitrectomy Instrumentation Usage Over Time

MIGS Stents Trend